Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Combination Versus Insulin Glargine Alone on Top of Metformin in Type 2 Diabetic Patients

NCT01476475 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

323

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Insulin glargine /lixisenatide Fixed Ratio Combination
DRUG: Insulin glargine
DRUG: Metformin (Background drug)

Sponsor

Sanofi